sponsored
PatientsVille.com Logo

PatientsVille

Oxycontin and Mirtazapine

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectOxycontinMirtazapine
DEATH10.2% 1.7%
TOXICITY TO VARIOUS AGENTS8.1% 2.4%
OVERDOSE5.5% 1.5%
DRUG DEPENDENCE3.4% 0%
NAUSEA2.8% 2.4%
PAIN2.8% 1.4%
DRUG INTERACTION0.4% 2.4%
DRUG ABUSE2.3% 1.2%
FATIGUE1.7% 2.2%
COMPLETED SUICIDE0.7% 2.2%
DRUG INEFFECTIVE2.1% 2.1%
FALL1.2% 2.1%
VOMITING2% 1.8%
DIARRHOEA1.6% 2%
DEPRESSION1.4% 2%
ANXIETY1.3% 2%
CONFUSIONAL STATE0.8% 2%
DYSPNOEA1.5% 1.9%
DIZZINESS1% 1.9%
HEADACHE1.4% 1.7%
MALAISE1.2% 1.7%
SOMNOLENCE1.1% 1.6%
INSOMNIA1.1% 1.6%
DRUG ABUSER1.6% 0%
ASTHENIA1.2% 1.5%
TREMOR0.6% 1.5%
DRUG WITHDRAWAL SYNDROME1.5% 0.5%
CONSTIPATION1.3% 0.9%
SUICIDAL IDEATION0.6% 1.3%
AGITATION0.3% 1.3%
PNEUMONIA1.2% 1.2%
CONDITION AGGRAVATED0.5% 1.2%
SUICIDE ATTEMPT0% 1.2%
PYREXIA1% 1.1%
WEIGHT DECREASED1% 1.1%
DECREASED APPETITE0.9% 1.1%
BACK PAIN1.1% 0.7%
OFF LABEL USE0.7% 1.1%
HYPOTENSION0.5% 1.1%
ARTHRALGIA1% 1%
HYPERHIDROSIS0.7% 1%
LOSS OF CONSCIOUSNESS0.6% 1%
WEIGHT INCREASED0.5% 1%
HYPONATRAEMIA0% 1%
PAIN IN EXTREMITY0.9% 0.9%
GAIT DISTURBANCE0.5% 0.9%
INTENTIONAL OVERDOSE0% 0.9%
SEROTONIN SYNDROME0% 0.9%
TACHYCARDIA0% 0.9%
ABDOMINAL PAIN0.8% 0.8%
DEHYDRATION0.7% 0.8%
RASH0.8% 0.7%
FEELING ABNORMAL0.7% 0.8%
HYPERTENSION0.6% 0.8%
MUSCLE SPASMS0.5% 0.8%
URINARY TRACT INFECTION0.5% 0.8%
CARDIAC ARREST0.4% 0.8%
PARAESTHESIA0.4% 0.8%
AGGRESSION0% 0.8%
ACCIDENTAL OVERDOSE0.8% 0%
ANAEMIA0.7% 0.7%
OEDEMA PERIPHERAL0.7% 0.6%
HALLUCINATION0.3% 0.7%
DRUG WITHDRAWAL SYNDROME NEONATAL0.7% 0%
SYNCOPE0% 0.7%
DYSPHAGIA0% 0.7%
ACUTE KIDNEY INJURY0% 0.7%
MALIGNANT NEOPLASM PROGRESSION0.7% 0%
ELECTROCARDIOGRAM QT PROLONGED0% 0.7%
CHEST PAIN0.6% 0.6%
PRURITUS0.6% 0.6%
HYPOAESTHESIA0.5% 0.6%
ABDOMINAL PAIN UPPER0.6% 0.5%
COMA0.4% 0.6%
MEMORY IMPAIRMENT0.4% 0.6%
MYALGIA0.4% 0.6%
RESTLESSNESS0% 0.6%
PALPITATIONS0% 0.6%
DRUG HYPERSENSITIVITY0.6% 0%
CONVULSION0% 0.6%
COUGH0.5% 0.5%
HAEMOGLOBIN DECREASED0.4% 0.5%
CARDIO-RESPIRATORY ARREST0.4% 0.5%
GENERAL PHYSICAL HEALTH DETERIORATION0.4% 0.5%
PULMONARY EMBOLISM0.4% 0.5%
RENAL FAILURE0.4% 0.5%
VISION BLURRED0.3% 0.5%
CEREBROVASCULAR ACCIDENT0.3% 0.5%
DELIRIUM0.3% 0.5%
SOPOR0% 0.5%
SEIZURE0% 0.5%
WITHDRAWAL SYNDROME0% 0.5%
SLEEP DISORDER0% 0.5%
DYSKINESIA0% 0.5%
DISORIENTATION0% 0.5%
RHABDOMYOLYSIS0% 0.5%
DISTURBANCE IN ATTENTION0% 0.5%
RESTLESS LEGS SYNDROME0% 0.5%
DEPRESSED MOOD0% 0.5%
BALANCE DISORDER0% 0.5%
DIABETES MELLITUS0% 0.5%
ALANINE AMINOTRANSFERASE INCREASED0% 0.5%
PSYCHOTIC DISORDER0% 0.5%
DEPRESSED LEVEL OF CONSCIOUSNESS0% 0.5%
NIGHTMARE0% 0.5%
NEUTROPENIA0% 0.5%
INADEQUATE ANALGESIA0.5% 0%
DRUG EFFECT DECREASED0.5% 0%
SUBSTANCE ABUSE0.5% 0%
MYOCARDIAL INFARCTION0.5% 0%
DISEASE PROGRESSION0.5% 0%
SEPSIS0.4% 0%
INTENTIONAL PRODUCT MISUSE0.4% 0%
CHILLS0.4% 0%
INFECTION0.4% 0%
PLATELET COUNT DECREASED0.4% 0%
NEUROPATHY PERIPHERAL0.4% 0%
ROAD TRAFFIC ACCIDENT0.4% 0%
AMNESIA0.4% 0%
ABDOMINAL DISCOMFORT0.4% 0%
BLOOD PRESSURE INCREASED0.4% 0%
MULTIPLE DRUG OVERDOSE0.3% 0%
THROMBOCYTOPENIA0.3% 0%
PLEURAL EFFUSION0.3% 0%
DRUG DOSE OMISSION0.3% 0%
WHITE BLOOD CELL COUNT DECREASED0.3% 0%
UNEVALUABLE EVENT0.3% 0%
ERYTHEMA0.3% 0%
DEEP VEIN THROMBOSIS0.3% 0%
MUSCULAR WEAKNESS0.3% 0%

New treatments are found every day. View current Oxycontin research studies and Mirtazapine clinical trials

1